U.S. vaccinated 600,000 12-15 year olds last week -health official
Reuters
Published May 18, 2021 11:12AM ET
Updated May 18, 2021 03:53PM ET
By Carl O'Donnell
(Reuters) -The United States administered COVID-19 vaccinations to around 600,000 children ages 12 to 15 last week after regulators cleared Pfizer (NYSE:PFE) Inc’s and BioNTech’s shots for use in that age group, U.S. Centers for Disease Control and Prevention Director Rochelle Walensky said in a media call on Tuesday.
In total, more than 4 million people under 17 have been vaccinated in the United States so far, she added. Top U.S. infectious disease specialist Anthony Fauci said he expects that by the end of 2021 the United States will have enough safety data to vaccinate children of any age.
U.S. regulators last week authorized Pfizer’s COVID-19 vaccine for use in children as young as 12. Most states began issuing shots to children last Thursday but some, including Georgia, started sooner. [L1N2MY3AX]
Pfizer’s shot is the first to be cleared in the United States for children 12 to 15. Vaccinating younger ages is considered important for getting children back into schools safely. U.S. President Joe Biden has asked states to make the vaccine available to younger adolescents immediately. [L1N2MX2HO]
The vaccine has been available under an emergency use authorization to people as young as 16 in the United States since December.
Most children with COVID-19 develop only mild symptoms or no symptoms. Yet children remain at risk of becoming seriously ill, and they can spread the virus.
Widely vaccinating 12- to 18-year olds could allow U.S. schools and summer camps to relax masking and social distancing measures suggested by the CDC.
Fauci also said on Tuesday that existing COVID-19 shots probably also protect against the new variant of the coronavirus first found in India, which has been battling the world's biggest jump in COVID-19 infections.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.